Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.

Fujieda M, Yamazaki H, Saito T, Kiyotani K, Gyamfi MA, Sakurai M, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H, Kamataki T. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis. 2004 Dec; 25(12):2451-8.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aryl Hydrocarbon Hydroxylases
Carcinoma, Small Cell
Carcinoma, Squamous Cell
Case-Control Studies
Genotype
Humans
Lung Neoplasms
Male
Middle Aged
Mixed Function Oxygenases
Odds Ratio
Polymorphism, Genetic
Risk Factors
Smoking

authors with profiles

Maxwell Gyamfi

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support